DLL3 and small cell lung carcinoma: A recent study published by Obermayr et al. [48] demonstrated that the DLL3 transcript can be detected together with SYP and CHGA in the CTC-enriched fraction of blood samples of SCLC patients using a combination of Parsortix’s technology selection and RT-qPCR (8% and 25%, respectively).